Valeant Pharmaceuticals International Inc (NYSE:VRX)

197.48
Delayed Data
As of Feb 27
 -3.77 / -1.87%
Today’s Change
106.00
Today|||52-Week Range
204.66
+37.99%
Year-to-Date

Today’s Trading

Previous close201.25
Today’s open200.46
Day’s range-- - --
Volume6,588,161
Average volume (3 months)2,606,587
Market cap$65.9B
Dividend yield--
Data as of 02/27/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+25.40%
Earnings growth (next 5 years)+25.10%
Revenue growth (last year)+43.22%
P/E ratio--
Price/Sales5.83
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AGNAllergan+0.34+0.15%
ABTAbbott Laboratories-0.24-0.50%
LLYEli Lilly and Co+0.14+0.20%
ACTActavis+1.58+0.55%
Data as of 02/27/2015

Financials

Next reporting dateApril 30, 2015
EPS forecast (this quarter)$2.31
Annual revenue (last year)$8.3B
Annual profit (last year)$913.5M
Net profit margin11.05%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
J. Michael Pearson
Chief Financial Officer, Director &
Executive VP
Howard Bradley Schiller
Corporate headquarters
Laval, Quebec

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account